Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-683,463
Closed -$47.5M 123
2026
Q1
$47.5M Buy
683,463
+14,843
+2% +$1.14M 0.58% 39
2025
Q4
$50.9M Sell
668,620
-54,223
-8% -$4.35M 0.7% 37
2025
Q3
$62.3M Buy
722,843
+4,147
+0.6% +$313K 0.82% 24
2025
Q2
$49M Sell
718,696
-142,048
-17% -$8.8M 0.78% 25
2025
Q1
$51.2M Buy
860,744
+351,095
+69% +$22.3M 1.07% 24
2024
Q4
$30.8M Buy
509,649
+36,760
+8% +$2.25M 0.7% 41
2024
Q3
$34.1M Buy
472,889
+74,920
+19% +$5.23M 0.84% 38
2024
Q2
$28M Buy
397,969
+23,982
+6% +$1.84M 0.76% 44
2024
Q1
$29.8M Buy
373,987
+10,684
+3% +$862K 0.78% 40
2023
Q4
$32.6M Buy
+363,303
New +$31.3M 0.83% 38

Other funds holding APTV

Sarah Ketterer's APTV Position: Q2 2026 in Review

Sarah Ketterer sold out of Aptiv (APTV) in Q2 2026, closing a stake of 683,463 shares — an estimated $47.5M sold.

Sarah Ketterer first reported a position in APTV in Q4 2023 and held it in 10 quarters. The position peaked at $62.3M in Q3 2025. 655 funds tracked by Wall St. Rank hold APTV as of Q2 2026.

  • Sarah Ketterer reported no remaining Aptiv position as of Q2 2026 after selling out during the quarter.
  • Sarah Ketterer sold 683,463 Aptiv shares in Q2 2026, an estimated $47.5M.
  • Sarah Ketterer first reported a position in Aptiv in Q4 2023 and held it in 10 quarters.
  • Sarah Ketterer's Aptiv position peaked at $62.3M in Q3 2025.
  • 655 funds tracked by Wall St. Rank held Aptiv as of Q2 2026.

Based on Causeway Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.